Photobiomodulation: Science-Backed Joint Comfort
What a Rigorous Clinical Trial Reveals About Light, Joint Comfort, and the Science of Moving Better
A placebo-controlled trial in Lasers in Medical Science found photobiomodulation significantly improved knee comfort, stiffness, and daily function—here's what that means.
A double-blind, randomized controlled trial published in June 2025 found that participants receiving near-infrared photobiomodulation reported significantly greater improvements in knee comfort and daily function compared to those receiving a sham treatment or no intervention at all. The finding matters not because it is surprising to those who follow biophoton and light-energy research—but because of how rigorously it was demonstrated. When the science is this carefully constructed, the results are worth understanding in full.
Why the Study Design Matters as Much as the Results
Not all wellness research is built the same way. The difference between a compelling testimonial and a meaningful finding often comes down to one question: did researchers account for the placebo effect?
This trial, published in Lasers in Medical Science by Maciel and colleagues, did exactly that. Sixty-five participants were divided into three groups: one received active photobiomodulation (PBM), one received a sham treatment designed to mimic the real intervention without delivering therapeutic light, and one received no intervention at all. Neither participants nor evaluators knew who was receiving which treatment—a double-blind design that meets the CONSORT guidelines for non-pharmacological clinical research.
The significance of this structure cannot be overstated. When an active intervention outperforms both a convincing placebo and a no-treatment control, the observed changes are far more likely to reflect the actual effects of the intervention. That is precisely what happened here. The PBM group showed significant improvements. The sham and control groups did not. That is the kind of evidence that earns attention.
The Protocol Details That Separate Precision From Vague "Light Therapy"
One of the most instructive aspects of this trial is its specificity. The researchers did not simply apply "light therapy" and measure results. They followed the recommendations of the World Association for Laser Therapy (WALT), using a 790 nm wavelength laser at 120 mW of power, delivering 4 joules per point across nine precisely defined areas of the knee.
Why does this level of detail matter? Because light-based therapies are not monolithic. Wavelength, power output, energy dose, and application site all influence how photons interact with biological tissue. A 790 nm near-infrared wavelength, for example, falls within what researchers refer to as the "optical window" of tissue—a range in which light can penetrate more deeply into the body than visible wavelengths allow. Applying that light to nine specific anatomical points around the knee, rather than broadly over the joint, reflects a deliberate, evidence-informed approach to where and how energy is delivered.
For anyone exploring light-based or biophoton wellness modalities, this trial serves as a reminder that specificity is not a bureaucratic detail. It is the foundation of reproducible, meaningful outcomes.
From Pain Scores to Daily Function: What the Outcomes Actually Measured
The trial used three validated, patient-reported outcome tools: the Visual Analog Scale (VAS) for pain, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the Knee Injury and Osteoarthritis Outcome Score (KOOS). Each of these instruments captures a different dimension of what it actually feels like to live in a body that is struggling with joint comfort.
VAS scores reflect how much discomfort a person is experiencing in a given moment. WOMAC goes further—it separately evaluates pain, joint stiffness, and functional limitations in daily activities like walking, climbing stairs, and rising from a seated position. KOOS adds a quality-of-life dimension, asking how the knee affects a person's ability to participate in sport, recreation, and everyday life.
The PBM group showed significant pre-to-post improvements across all of these domains. The sham and control groups did not show significant changes. This distinction is important: the trial was not only measuring whether people felt less discomfort in the moment—it was measuring whether they could move through their day more easily. That is a different and more meaningful question, and the results were consistent across all three measurement tools.
The Cellular Pathway Researchers Propose Is Behind It
Understanding why near-infrared light may support tissue comfort and function requires a brief look at cellular biology. Researchers in this field have proposed that a protein called cytochrome c oxidase—a key component of the mitochondrial respiratory chain—acts as a primary photoacceptor for red and near-infrared wavelengths.
The hypothesis, which the authors of this trial reference as a proposed mechanism (and which was not directly measured in this study), is that when cytochrome c oxidase absorbs photons of the right wavelength, it may support the mitochondria's ability to produce cellular energy in the form of ATP. Mitochondria are the energy-generating centers of virtually every cell in the body. When they function more efficiently, the tissues they power—including those in and around joints—may be better supported in their natural processes of repair, maintenance, and adaptation.
This is not a claim that light therapy repairs damaged tissue in a direct, mechanical sense. It is a proposed pathway through which cellular energy metabolism may be supported by specific wavelengths of light. The distinction matters. The body's capacity for self-regulation and recovery is remarkable. What research like this explores is whether targeted light exposure may support the conditions under which that capacity can express itself more fully.
What "Significant" Means—and What It Doesn't
The word "significant" appears throughout clinical research, and it is worth being precise about what it means in this context. When the study reports that improvements in the PBM group were statistically significant (p < 0.05) while changes in the sham and control groups were not, it means the observed differences were unlikely to be due to chance alone—not that every participant experienced dramatic changes, or that the results would apply identically to every person in every context.
What the trial does establish is a structured, reproducible signal: under defined conditions, with a specific near-infrared protocol applied to a specific population, active photobiomodulation was associated with measurably greater improvements in self-reported comfort, stiffness, and functional ability compared to both placebo and no treatment. That is a meaningful finding, honestly stated.
For those exploring biophoton and light-energy wellness modalities, this kind of evidence supports a grounded, calibrated conversation—one that neither overpromises nor dismisses what the research is genuinely showing.
The Bottom Line
The science of light-based cellular support is advancing, and trials like this one—rigorous, placebo-controlled, and outcome-rich—are part of why the conversation is worth having. Near-infrared photobiomodulation, delivered with precision and measured with validated tools, was associated with meaningful improvements in comfort, stiffness, and daily function in a well-designed clinical setting. The body has a remarkable capacity for self-regulation. Research like this explores what it looks like to support that capacity at the cellular level.
If you want to go deeper into the biophoton research that informs our approach to wellness technology, the library is waiting for you.
References
Maciel, T. D. S., Chamy, N. C. L., Maciel, M. D. S., & Marques, A. P. (2025). Effect of photobiomodulation (low-level laser therapy) in patients with knee osteoarthritis: A randomized controlled trial. Lasers in Medical Science. https://doi.org/10.1007/s10103-025-04440-5
Disclaimer: We're thrilled that thousands of users have shared positive experiences with our products and services, which may also have been verified through clinical studies. However, our products aren't yet FDA-approved to diagnose, treat, cure, or prevent any disease. We encourage you to explore our scientific publications for insights into our ongoing research. If you're managing a health condition, please discuss this with your healthcare provider before using our products. Your safety and well-being are our highest priority. For further assistance, or more information about our published studies, please contact our headquarters. Thank you!
